FASEB Journal

The FASEB Journal is among the world's most cited biology journals. It is a preferred venue for the latest research reports and reviews of epigenetics, iRNA mechanics, histone acetylation, nitric oxide signaling, eicosanoid biochemistry, angiogenesis, tumor suppressor genes, apoptosis, cytoskeletal function, and human stem cell research. We publish international, transdisciplinary research covering all fields of biology at every level of organization: atomic, molecular, cell, tissue, organ, organismic and population. While we strive to include research that cuts across the biological sciences, we also consider submissions that lie within one field, but may have implications for other fields as well. We seek to publish basic and translational research, but also welcome reports of pre-clinical and early clinical research. In addition to research, review, and hypothesis submissions, we also seeks perspectives, commentaries, book reviews, and similar content related to the life sciences in its Up Front section. 

Publisher
Federation of American Societies for Experimental Biology
History
1912 -- present
Impact factor
6.515 (2010)

Some content from Wikipedia, licensed under CC BY-SA

Oncology & Cancer

PML as potential treatment for pancreatic cancer

A recent study in The FASEB Journal identifies a new mechanism of pancreatic tumors' resistance to chemotherapeutic treatment. The mechanism involves the loss of function of promyelocytic leukemia protein (PML), which operates ...

Surgery

Researchers identify factor essential for tendon growth

Insulin-like growth factor 1 (IGF1) is essential for allowing tendons to adapt to physical activity and grow properly, according to basic science research by investigators at Hospital for Special Surgery (HSS). The findings ...

Medical research

Researchers find bitter taste receptors on human hearts

A team of University of Queensland researchers is investigating the surprising discovery that smell and taste receptors normally found in the nose and mouth can also be present on the human heart.

Oncology & Cancer

Existing drug could treat aggressive brain cancer

A research team from the University of Georgia's Regenerative Bioscience Center has found that a compound molecule used for drug delivery of insulin could be used to treat glioblastoma, an aggressive, usually fatal form of ...

Inflammatory disorders

Watching the inflammation process in real time

Junior Scientist from the Jena University develops a test system for the search for new active ingredients: Dr. Ulrike Garscha and her colleagues from Jena together with scientists from the Karolinska Institute in Stockholm ...

Medical research

Research breakthrough in fight against muscle wasting diseases

It is estimated that half of all cancer patients suffer from a muscle wasting syndrome called cachexia. Cancer cachexia impairs quality of life and response to therapy, which increases morbidity and mortality of cancer patients. ...

page 1 from 33